Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone:results of a 24-week double-blind placebo-controlled study

Autor: Drent, M L, Tollefsen, A T M, van Heusden, F H J A, Hoenderdos, E B M, Jonker, J J C, van der Veen, E A

Publikováno v: Drent, M L, Tollefsen, A T M, van Heusden, F H J A, Hoenderdos, E B M, Jonker, J J C & van der Veen, E A 2002, ' Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone : results of a 24-week double-blind placebo-controlled study ', Diabetes, nutrition & metabolism, vol. 15, no. 3, pp. 152-9 .

AIMS: A double-blind randomised study was performed to compare the dose-effect and dose-tolerability relationships between the alpha-glucosidase inhibitor miglitol in doses of 25 mg, 50 mg, 100 mg and 200 mg all t.i.d. vs placebo t.i.d. in patients w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10172::2fc02177b194ee36139c7375dfa5d042
https://research.vumc.nl/en/publications/eeb7c94f-3a8f-4b2b-a315-e04a935c5bff